🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 20 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/11/1985 | 3,22 | 3,22 | 3,20 | 3,22 | -0,10% | 0,61% | 2.769.235 |
| 18/11/1985 | 3,23 | 3,24 | 3,21 | 3,22 | -0,51% | 1,13% | 5.519.606 |
| 15/11/1985 | 3,22 | 3,26 | 3,20 | 3,24 | +0,41% | 1,75% | 7.824.787 |
| 14/11/1985 | 3,20 | 3,23 | 3,20 | 3,23 | +0,62% | 1,04% | 2.659.824 |
| 13/11/1985 | 3,24 | 3,24 | 3,20 | 3,21 | -1,43% | 1,23% | 3.712.435 |
| 12/11/1985 | 3,23 | 3,27 | 3,22 | 3,25 | +0,41% | 1,54% | 6.855.178 |
| 11/11/1985 | 3,17 | 3,24 | 3,17 | 3,24 | +2,52% | 2,41% | 8.383.162 |
| 08/11/1985 | 3,11 | 3,16 | 3,10 | 3,16 | +1,38% | 1,92% | 7.398.461 |
| 07/11/1985 | 3,14 | 3,14 | 3,11 | 3,12 | -1,05% | 0,95% | 4.180.262 |
| 06/11/1985 | 3,17 | 3,17 | 3,13 | 3,15 | -0,63% | 1,25% | 9.337.680 |
| 05/11/1985 | 3,18 | 3,18 | 3,14 | 3,17 | -0,31% | 1,04% | 7.160.774 |
| 04/11/1985 | 3,12 | 3,18 | 3,12 | 3,18 | +2,02% | 2,02% | 11.597.587 |
| 01/11/1985 | 3,08 | 3,12 | 3,08 | 3,12 | +0,97% | 1,29% | 7.511.645 |
| 31/10/1985 | 3,06 | 3,09 | 3,05 | 3,09 | +0,65% | 1,08% | 12.918.067 |
| 30/10/1985 | 3,04 | 3,07 | 3,03 | 3,07 | +1,76% | 1,20% | 8.217.158 |
| 29/10/1985 | 2,98 | 3,02 | 2,97 | 3,02 | +1,56% | 1,78% | 4.595.270 |
| 28/10/1985 | 2,97 | 2,98 | 2,96 | 2,97 | -0,11% | 0,67% | 2.678.688 |
| 25/10/1985 | 2,98 | 2,99 | 2,97 | 2,97 | -0,34% | 0,45% | 2.014.675 |
| 24/10/1985 | 3,00 | 3,00 | 2,98 | 2,98 | -0,44% | 0,77% | 6.379.805 |
| 23/10/1985 | 3,00 | 3,00 | 2,98 | 3,00 | -0,22% | 0,44% | 5.255.510 |
| 22/10/1985 | 2,99 | 3,01 | 2,98 | 3,00 | +0,55% | 1,11% | 5.406.422 |
| 21/10/1985 | 3,01 | 3,02 | 2,99 | 2,99 | -0,99% | 0,99% | 2.286.317 |
| 18/10/1985 | 3,02 | 3,03 | 3,00 | 3,02 | -0,22% | 0,99% | 10.228.061 |
| 17/10/1985 | 3,00 | 3,03 | 2,99 | 3,02 | +0,88% | 1,55% | 14.495.098 |
| 16/10/1985 | 2,91 | 3,00 | 2,90 | 3,00 | +3,08% | 3,19% | 12.499.286 |
| 15/10/1985 | 2,90 | 2,91 | 2,88 | 2,91 | +0,00% | 0,91% | 3.414.384 |
| 14/10/1985 | 2,90 | 2,91 | 2,90 | 2,91 | +0,11% | 0,46% | 1.867.536 |
| 11/10/1985 | 2,89 | 2,90 | 2,89 | 2,90 | +0,81% | 0,58% | 4.097.261 |
| 10/10/1985 | 2,88 | 2,89 | 2,87 | 2,88 | -0,34% | 0,69% | 2.761.690 |
| 09/10/1985 | 2,89 | 2,91 | 2,89 | 2,89 | -0,68% | 0,69% | 4.263.264 |